The Use of Remdesivir in Patients with COVID-19.
Afshar ZM, Hosseinzadeh D, Hosseinzadeh R, Babazadeh A, Allahgholipour A, Sio TT, Sullman MJM, Carson-Chahhoud K, Barary M, Ebrahimpour S.
Afshar ZM, et al.
Infect Disord Drug Targets. 2023;23(7):1-13. doi: 10.2174/1871526523666230509110907.
Infect Disord Drug Targets. 2023.
PMID: 37165585